Donal Skelly retweeted
We held a thank you event in Oxford today
@OUHospitals @OxfordBRC for our OPTIC/PITCH/@vibrant_uk healthcare worker participants. Fab to hear all our participants' Qs on what we have achieved, immunity of "Never Nevers" etc. Great organising from Sofia/Lizzie/Anni/Callum & all
Donal Skelly retweeted
People with three vaccine doses neutralise BA.4 and BA.5 less well than they do earlier Omicron sub-lineages, a @UniofOxford team discovered last month in a study supported by @UKCICstudy.
Their findings could explain repeat Omicron reinfections.
👇
uk-cic.org/publication/antib…
Donal Skelly retweeted
Thrilled to see our work on the durability of immune memory responses to #COVID19 finally published in @NatureComms This work wouldn't be possible without incredible team @Susannajd @EleanorBarnesOx @PKlenermanLab @aneogbe @DanScholar @skellydonal Chris Dold @pitchstudy 🧵👇
***New #COVID19 preprint alert*** researchsquare.com/article/r… Happy to share our recent work on how immune response changes 6 months after natural infection. (1/n)
Donal Skelly retweeted
1/ Proud to be part of this @pitchstudy ‘Immunogenicity of standard and extended dosing intervals of @pfizer BNT162b2 mRNA vaccine’ which is out in @CellCellPress cell.com/cell/fulltext/S0092…
Thread below 👇
Donal Skelly retweeted
Our @pitchstudy comparing standard and extended dosing intervals of @pfizer BNT162b2 mRNA vaccine is out now @CellCellPress. Great collaboration with @AlexRichter3 @Susannajd @chrisjaduncan @LanceTurtle @Thushan_deSilva @Carroll_Lab_Ox and Screaton lab. cell.com/cell/fulltext/S0092…
Donal Skelly retweeted
Our @pitchstudy paper on the impact of Pfizer dosing interval (which we preprinted in July) is now live @CellCellPress. Many thanks to all our many collaborators & the HCWs who participated @LanceTurtle @Thushan_deSilva @Carroll_Lab_Ox @AlexRichter3 @chrisjaduncan Chris Dold – at Oxford, England
This Post is from an account that no longer exists. Learn more
Donal Skelly retweeted
Honoured to be a part of this with @skellydonal writing about systemic inflammation, #delirium and #dementia
Absolutely thrilled to see our Textbook of Immunopsychiatry in flesh!
Product of 2y of blood, sweat & (mostly) tears! Hope you enjoy reading it.
Thanks to co-editors @Immunopsyc @edbullmore Robert & our international expert contributors.
Donal Skelly retweeted
ICYMI 📰 Antibody levels and ‘helper’ T cells are boosted after a ~10 week interval between 2 doses of the Pfizer #COVID19 vaccine
This @PITCHstudy research involved 5 UK centres 🤝 @UniofOxford @LivUni @sheffielduni @UniofNewcastle @unibirmingham
👉 uk-cic.org/news/longer-inter…
Donal Skelly retweeted
***New #COVID19 preprint alert*** researchsquare.com/article/r… Happy to share our recent work on how immune response changes 6 months after natural infection. (1/n)
Donal Skelly retweeted
V happy to get our @pitchstudy led by @Thushan_deSilva out today. Thanks++ to all @OxfordBRC @OUHospitals @NDMOxford who worked hard on this especially @EleanorBarnesOx @skellydonal @johnson_sile @pippa_matt @patpongrongkard @drkochi @aneogbe @JohnFrater5 @AzimAnsa @bonytown
Our paper on immune responses to COVID vaccine (mostly Pfizer) in 237 healthcare workers, 124 #SARSCoV2 naïve and 113 previously infected, from the PITCH consortium @pitchstudy is out as a pre-print today.
papers.ssrn.com/sol3/papers.…
@pitchstudy
@DHSCgovuk
@UKCICstudy
@PHE_uk
1/16
Donal Skelly retweeted
#COVID19 One Year On | Vaccine and Variants: Implications for Clinicians
A new series of online events kicks off next week with this webinar; join expert speakers Prof Karina Butler, Dr Donal Skelly and Prof Paddy Mallon.
Find out more & book your place➡bit.ly/3kqvdvg
Donal Skelly retweeted
Great to see our PITCH pre-print researchsquare.com/article/r… of work supported by @DHSCgovuk and @UKCICstudy referenced by Nature @WilliamSiwJames @EleanorBarnesOx @Susannajd @skellydonal nature.com/articles/d41586-0…
Donal Skelly retweeted
Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern. | Research Square. First author Dr Donal Skelly from Waterford leading on this important research on vaccine efficacy researchsquare.com/article/r…
Delighted that a pre-print of our study examining antibody and T cell immunity resulting from natural infection and Pfizer vaccination on VOC (B1.1.7 & B1.351) is out today. Thanks to the large, diverse and brilliant teams involved.
researchsquare.com/article/r…
Donal Skelly retweeted
NEW: a common response to reports of hospitals struggling this winter is "it’s no different to a bad flu season!"
I’ve tracked down historical data on flu ICU admissions, including winter 2017-18, a record high.
Here’s how England’s Covid winter compares to a bad flu season 📹
Donal Skelly retweeted
I am excited to post this advert for a new post-doctoral post in our lab, working on neuroinflammation, #delirium and brain energy metabolism, in collaboration with John Newman @GeriSciDoc . I would really appreciate some RETWEETs to help it find its audience !
Donal Skelly retweeted
This Saturday-entire year of med students gave blood for COVID serology and T cell analysis @OUH_Research. Brilliantly organised by @skellydonal and @LizzieStaffor15 @dcodonnell and others. Three huge labs collaborating @TaoDong14 @OxfordVacGroup @Susannajd. Went like a machine
Donal Skelly retweeted
Our healthcare worker pre-print explored T cell responses to SARS-CoV-2 in 168 people post COVID-19 & 118 people who don't appear to have had the virus using several different lab assays that measure how T cells react to key proteins in the virus 1/7 medrxiv.org/content/10.1101/…
























